sotatercept

Merck wins UK approval for lung disease drug acquired in $11 billion deal
MSN/Reuters
Thu, 01/2/25 - 11:22 am
Merck
UK
sotatercept
Winrevair
PAH
Merck preps filings after blockbuster-in-waiting Winrevair succeeds in severe PAH study
Fierce Pharma
Mon, 11/25/24 - 09:52 am
Merck
Acceleron
Winrevair
sotatercept
PAH
clinical trials
Merck scores key FDA approval for pulmonary arterial hypertension drug Winrevair
Fierce Pharma
Wed, 03/27/24 - 11:22 am
Merck
FDA
PAH
Winrevair
sotatercept
Acceleron
Merck’s next big thing is (probably) on the way
Stat
Tue, 03/26/24 - 11:03 am
Merck
FDA
sotatercept
PAH
FDA gives Merck priority review for blood vessel disorder therapy sotatercept
Medical Marketing and Media
Thu, 09/28/23 - 11:42 pm
Merck
PAH
sotatercept
FDA
Merck keeps pumping up sotatercept, posting fresh data ahead of FDA approval ruling
Fierce Biotech
Mon, 09/11/23 - 12:35 pm
Merck
sotatercept
FDA
cardiovascular disease
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Gossamer could put pressure on Merck
EP Vantage
Fri, 11/11/22 - 10:26 am
Merck
Gossamer Bio
PAH
sotatercept
United Therapeutics
ralinepag
Sotatercept- the breakthrough PAH has been waiting for?
Clinical Trials Arena
Thu, 11/10/22 - 10:31 am
Merck
sotatercept
Acceleron
PAH
Is Merck Moving Toward Another Blockbuster Drug Launch?
Motley Fool
Wed, 10/26/22 - 10:32 am
Merck
sotatercept
PAH
Merck nails phase 3 sotatercept win, making good on its $11.5B Acceleron buy
Fierce Biotech
Mon, 10/10/22 - 11:06 am
Merck
Acceleron
clinical trials
sotatercept
PAH
pulmonary arterial hypertension
Merck & Co justifies paying up for Acceleron
EP Vantage
Fri, 10/1/21 - 10:46 am
Merck
Accleron
M&A
sotatercept
Reblozyl
PAH
Merck emerges as lead bidder in potential Acceleron buyout with deal possible this week — report
Endpoints
Tue, 09/28/21 - 12:15 am
Merck
Acceleron
M&A
PAH
sotatercept
Acceleron uncorks more mid-stage data for PAH drug sotatercept as part of the drug's resurrection campaign
Endpoints
Wed, 05/19/21 - 10:42 am
Acceleron
sotatercept
PAH
Acceleron's PAH drug gets the FDA's red carpet treatment with breakthrough status
Endpoints
Wed, 04/8/20 - 10:37 am
Acceleron
PAH
FDA
breakthrough therapy
sotatercept
Acceleron’s post-Reblozyl plan comes together
EP Vantage
Tue, 01/28/20 - 11:09 am
Acceleron
sotatercept
PAH
JNJ
Bellerophon Therapeutics
United Therapeutics
Vivus
Arena
Novartis
Acceleron Shares Surge as Its Hypertension Drug Meets Trial Endpoints
Motley Fool
Mon, 01/27/20 - 10:47 pm
Acceleron
PAH
clinical trials
sotatercept
Acceleron gets FDA orphan drug designation for sotatercept in pulmonary arterial hypertension
Pharmaceutical Business Review
Tue, 09/10/19 - 11:06 am
Acceleron
orphan drugs
sotatercept
PAH
Celgene anemias treatment granted FDA orphan designation
Yahoo/Fly on the Wall
Tue, 04/29/14 - 09:43 am
FDA
Celgene
anemia
sotatercept
Acceleron, Celgene Vs. Amgen In The Anemia Drug Race
Seeking Alpha
Mon, 12/30/13 - 11:15 am
Amgen
Acceleron
Celgene
anemia
sotatercept
ACE-536